|
You are here: Home: BCU Surgeons 2004 Vol 3 Issue 1: Financial Disclosures
FINANCIAL DISCLOSURES
As a provider accredited by the ACCME, it is the policy of Research To Practice to require the disclosure of any significant financial interest or any other relationship the sponsor or faculty members have with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The presenting faculty reported the following:
|
| Harry D Bear, MD, PhD |
Consultant: Aventis Pharmaceuticals Inc |
| Anthony Howell, MD, MSc, FRCP |
No financial interests or affiliations to disclose |
| Eleftherios P Mamounas, MD, MPH, FACS |
Consultant: Aventis Pharmaceuticals Inc, AstraZeneca
Pharmaceuticals LP, Eli Lilly & Company, Bristol-Myers Squibb Company, Novartis Pharmaceuticals Corporation Honorarium: Aventis Pharmaceuticals Inc, AstraZeneca Pharmaceuticals LP, Ortho Biotech Products LP |
| Edith A Perez, MD |
Grants/Research Support: Bristol-Myers Squibb Company, Genentech BioOncology, Aventis Pharmaceuticals Inc, Pharmacia Corporation |
This educational activity includes discussion of published and/or investigational uses of agents that are not indicated by the FDA. Research To Practice does not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. The opinions expressed are those of the presenters and are not to be construed as those of the publisher or grantor.
|
|
|
|
